Free Trial

Merck KGaA (OTCMKTS:MKGAF) Sees Large Decrease in Short Interest

Merck KGaA logo with Medical background

Merck KGaA (OTCMKTS:MKGAF - Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 15th, there was short interest totaling 386,000 shares, a drop of 24.4% from the July 31st total of 510,800 shares. Based on an average daily trading volume, of 2,700 shares, the short-interest ratio is currently 143.0 days. Based on an average daily trading volume, of 2,700 shares, the short-interest ratio is currently 143.0 days.

Merck KGaA Stock Performance

Shares of OTCMKTS MKGAF traded down $6.86 during midday trading on Friday, reaching $123.39. The company had a trading volume of 227 shares, compared to its average volume of 991. The business's 50-day simple moving average is $129.47 and its 200 day simple moving average is $133.69. The stock has a market cap of $15.95 billion, a P/E ratio of 18.84 and a beta of 0.96. Merck KGaA has a 1 year low of $118.05 and a 1 year high of $193.00. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.